Pharmacokinetics of low doses of methotrexate in patients with psoriasis over the early period of treatment

Objective: The aim of the present study was to investigate the pharmacokinetics and pharmacodynamics of low-dose methotrexate (MTX) in the early phase (3 months) after the start of antipsoriatic therapy.